{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:21:37Z","timestamp":1773156097619,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ctrv.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T15:38:37Z","timestamp":1276184317000},"page":"637-646","source":"Crossref","is-referenced-by-count":17,"title":["Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies"],"prefix":"10.1016","volume":"36","author":[{"given":"Ulrike","family":"Bacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.moh.0000149608.29685.d1","article-title":"Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics","volume":"12","author":"Marcucci","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MOH.0b013e3280168490","article-title":"Insight into the molecular pathogenesis of myeloid malignancies","volume":"14","author":"Haferlach","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","article-title":"Cytogenetics and molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Mrozek","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ctrv.2010.05.002_bib4","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.ctrv.2010.05.002_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beha.2009.05.001","article-title":"Gene expression profiling in lymphoma diagnosis and management","volume":"22","author":"Iqbal","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beha.2005.11.006","article-title":"New agents for the treatment of acute myeloid leukemia","volume":"19","author":"Tallman","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.V99.3.759","article-title":"Acute promyelocytic leukemia: evolving therapeutic strategies","volume":"99","author":"Tallman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.seminhematol.2008.09.003","article-title":"Treatment of adult acute lymphoblastic leukemia","volume":"46","author":"Gokbuget","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children\u2019s oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2009.1.371","article-title":"Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"1","author":"Ottmann","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ctrv.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00277-007-0253-2","article-title":"Diagnostic pathways in acute leukemias: a proposal for a multimodal approach","volume":"86","author":"Haferlach","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/asheducation-2008.1.341","article-title":"Burkitt lymphoma in adults","volume":"1","author":"Perkins","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ctrv.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.2009.009647","article-title":"T cell\/histiocyte rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response","volume":"95","author":"Van Loo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ctrv.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications \u2013 a study from the Lunenburg Lymphoma Biomarker Consortium","volume":"25","author":"de Jong","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u2019s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/j.ctrv.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"iv67","DOI":"10.1093\/annonc\/mdn201","article-title":"Burkitt lymphoma versus diffuse large B-cell lymphoma","volume":"19","author":"Rosenwald","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood-2004-12-4938","article-title":"Global approach to the diagnosis of leukemia using gene expression profiling","volume":"106","author":"Haferlach","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2006-02-005538","article-title":"Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study","volume":"108","author":"Radmacher","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1182\/blood-2009-03-212688","article-title":"AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance","volume":"114","author":"de Jonge","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.pmed.0050035","article-title":"An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome","volume":"5","author":"Ebert","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/cncr.23789","article-title":"Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia","volume":"113","author":"Raza","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/leu.2009.18","article-title":"Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions","volume":"23","author":"Mullighan","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2008-04-153239","article-title":"A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects","volume":"113","author":"Wouters","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.beha.2007.11.008","article-title":"Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?","volume":"21","author":"Willman","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/4429","article-title":"Molecular interactions on microarrays","volume":"21","author":"Southern","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2010.05.002_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/4447","article-title":"High density synthetic oligonucleotide arrays","volume":"21","author":"Lipshutz","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2010.05.002_bib36","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/onc.2009.255","article-title":"A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes","volume":"28","author":"Careccia","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2010.05.002_bib37","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.21.9840","article-title":"New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia","volume":"27","author":"Tiu","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","article-title":"Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array","volume":"37","author":"Kawamata","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.leu.2404274","article-title":"Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks","volume":"20","author":"Staal","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gcc.20126","article-title":"Pattern robustness of diagnostic gene expression signatures in leukemia","volume":"42","author":"Kohlmann","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib41","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt1239","article-title":"The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements","volume":"24","author":"Shi","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1634\/theoncologist.12-3-301","article-title":"Is molecular profiling ready for use in clinical decision making?","volume":"12","author":"Ioannidis","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2010.05.002_bib43","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib44","series-title":"Multivariate analysis","author":"Mardia","year":"1979"},{"key":"10.1016\/j.ctrv.2010.05.002_bib45","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1200\/JCO.2005.02.8712","article-title":"Roadmap for developing and validating therapeutically relevant genomic classifiers","volume":"23","author":"Simon","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib46","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1073\/pnas.142103599","article-title":"Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles","volume":"99","author":"Schoch","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gcc.10198","article-title":"Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events","volume":"37","author":"Debernardi","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib48","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2004-03-1154","article-title":"Gene expression profiling of pediatric acute myelogenous leukemia","volume":"104","author":"Ross","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3324\/haematol.13299","article-title":"Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling","volume":"94","author":"Verhaak","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ctrv.2010.05.002_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.leu.2403746","article-title":"New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes","volume":"19","author":"Kohlmann","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/gcc.20193","article-title":"Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile","volume":"43","author":"Schoch","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib52","first-page":"1072","article-title":"Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes","volume":"89","author":"Lindvall","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.ctrv.2010.05.002_bib53","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1200\/JCO.2005.04.5450","article-title":"Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization","volume":"24","author":"Rucker","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10088","article-title":"Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH","volume":"35","author":"Schoch","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib57","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","article-title":"Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance","volume":"106","author":"Verhaak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood-2005-02-0560","article-title":"Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance","volume":"106","author":"Alcalay","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib59","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.leu.2404808","article-title":"Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias","volume":"21","author":"Mullighan","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood-2004-12-4633","article-title":"Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction","volume":"108","author":"Wilson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib61","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","article-title":"Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome","volume":"113","author":"Wouters","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2010.73","article-title":"Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways","author":"Kohlmann","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib63","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2003-12-4449","article-title":"Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes","volume":"104","author":"Lacayo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib64","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1182\/blood-2007-09-115055","article-title":"An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML","volume":"111","author":"Bullinger","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib65","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA expression profiles in acute myeloid leukemia with common translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib66","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-07-098749","article-title":"MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia","volume":"111","author":"Garzon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib67","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2008-01-133355","article-title":"MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia","volume":"111","author":"Jongen-Lavrencic","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.20175","article-title":"AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes","volume":"43","author":"Haferlach","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib69","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood-2009-03-211334","article-title":"Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status","volume":"114","author":"Silva","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib70","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1200\/JCO.2009.22.2547","article-title":"Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia","volume":"27","author":"Rao","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib71","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2007-09-112730","article-title":"A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia","volume":"111","author":"Raponi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib72","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/gcc.20573","article-title":"Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia","volume":"47","author":"Gupta","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib73","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2008-01-132431","article-title":"Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia","volume":"112","author":"Raghavan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib74","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/sj.leu.2404653","article-title":"DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups","volume":"21","author":"Suela","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib75","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood-2009-02-206946","article-title":"Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts","volume":"114","author":"Le Dieu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.beha.2009.04.006","article-title":"Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assays","volume":"22","author":"Galili","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2009.07720.x","article-title":"Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes","volume":"146","author":"Pellagatti","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib78","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"The clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2008-10-187203","article-title":"Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome (MDS)","volume":"114","author":"Mills","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib80","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1182\/blood-2009-08-236422","article-title":"Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression","volume":"114","author":"Sridhar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12185-008-0242-9","article-title":"Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome","volume":"89","author":"Prall","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib82","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood.V98.2.422","article-title":"Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction","volume":"98","author":"Miyazato","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1182\/blood-2007-01-068833","article-title":"Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q","volume":"111","author":"Raza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2010.05.002_bib85","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","article-title":"Classification of pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"102","author":"Ross","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib86","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood-2009-04-218123","article-title":"Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia","volume":"114","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib87","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/gcc.20709","article-title":"Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles","volume":"48","author":"Fulci","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2010.05.002_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cyto.b.10025","article-title":"Correlation of protein expression and gene expression in acute leukemia","volume":"55","author":"Kern","year":"2003","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.ctrv.2010.05.002_bib89","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1158\/1078-0432.CCR-04-2165","article-title":"Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation","volume":"11","author":"Chiaretti","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2010.05.002_bib90","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib91","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","article-title":"Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Acute Leukemia Working Party (GIMEMA AL WP)","volume":"114","author":"Iacobucci","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib94","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib95","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/0008-5472.CAN-04-2604","article-title":"Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis","volume":"65","author":"Irving","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2010.05.002_bib96","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood-2007-05-088310","article-title":"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray","volume":"111","author":"Kawamata","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib97","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2010.05.002_bib98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/leu.2009.203","article-title":"DNA copy-number abnormalities do not occur in infant ALL with t(4;11)\/MLL-AF4","volume":"24","author":"Bardini","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib99","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.leu.2403392","article-title":"Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays","volume":"18","author":"Willenbrock","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.05.002_bib100","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1200\/JCO.2007.14.4519","article-title":"Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children\u2019s Oncology Group Study","volume":"26","author":"Bhojwani","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib101","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2003-09-3243","article-title":"Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival","volume":"103","author":"Chiaretti","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib102","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2008.06981.x","article-title":"Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index","volume":"140","author":"Hoffmann","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib103","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(02)07678-X","article-title":"Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study","volume":"359","author":"Hofmann","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.05.002_bib105","first-page":"313","article-title":"Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy","volume":"31","author":"Zembutsu","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib106","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.05.002_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib108","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","article-title":"High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response","volume":"114","author":"Remke","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib109","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.05.002_bib110","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl. 3","key":"10.1016\/j.ctrv.2010.05.002_bib111","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.3816\/CLM.2009.s.015","article-title":"T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?","volume":"9","author":"Hoelzer","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.ctrv.2010.05.002_bib112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2005.05545.x","article-title":"Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia","volume":"130","author":"van Delft","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/asheducation-2008.1.400","article-title":"Molecular genetic pathways as therapeutic targets in acute myeloid leukemia","volume":"1","author":"Haferlach","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ctrv.2010.05.002_bib114","first-page":"1","article-title":"Evolving strategies in the treatment of MDS and AML","volume":"7","author":"Stone","year":"2009","journal-title":"Clin Adv Hematol Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.ctrv.2010.05.002_bib115","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3816\/CLM.2009.s.017","article-title":"Burkitt lymphoma\/leukemia: improving prognosis","volume":"9","author":"Kenkre","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.ctrv.2010.05.002_bib116","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00412-005-0002-z","article-title":"Molecular cytogenetics in haematological malignancy: current technology and future prospects","volume":"114","author":"Kearney","year":"2005","journal-title":"Chromosoma"},{"key":"10.1016\/j.ctrv.2010.05.002_bib117","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.05.002_bib118","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1158\/1078-0432.CCR-05-2552","article-title":"Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia","volume":"12","author":"Steinbach","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2010.05.002_bib119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature07638","article-title":"Transcriptome sequencing to detect gene fusions in cancer","volume":"458","author":"Maher","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2010.05.002_bib120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.1523","article-title":"Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing","volume":"27","author":"Gnirke","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ctrv.2010.05.002_bib121","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature07485","article-title":"DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome","volume":"456","author":"Ley","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2010.05.002_bib122","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1073\/pnas.0903091106","article-title":"Acquired copy number alterations in adult acute myeloid leukemia genomes","volume":"106","author":"Walter","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T16:45:09Z","timestamp":1591375509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737210001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":122,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0305737210001015"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2010.05.002","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}